Rare diseases
Investigational molecules
Locations
303 Wyman Street Suite 300, 02451-1255, United States
Research activity is centered on pulmonary hypertension associated with interstitial lung disease, a condition linking progressive lung scarring with elevated pressure in the pulmonary circulation. The sponsor’s clinical interest lies in therapies aimed at improving vascular function in this complex cardiopulmonary setting.
The trial landscape reflects a focus on treatment options for patients with combined vascular and fibrotic lung disease, with attention to clinically meaningful measures of pulmonary hemodynamics.
Pulmovant Inc. runs clinical trials in conditions such as Pulmonary hypertension, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
